Investors

The Common Stock of BioClinica, Inc. is listed on the NASDAQ Global Market under the symbol BIOC.

SIC Number: 8071
CIK Number: 0000822418
CUSIP Number: 09071B 100
Share Data at March 31,2010
Authorized: 36,000,000
Outstanding: 15,149,187
Symbol: BIOC
Exchange: NASDAQ

BioClinica will host second quarter financial results conference call on August 4, 2010 at 11:00am EDT. Click on the image below to listen to the WebCast.


Mark Weinstein contributes to “The Wall Street Transcript. Connecting Market Leaders with Investors.”

For more investment information, please contact us at ir@bioclinica.com

Click here to view our Transfer Agent, Company Counsel and Independent Auditors.